Please use this identifier to cite or link to this item:
Title: Insulin Management in Overweight or Obese Type 2 Diabetes Patients: the Role of Insulin Glargine
Authors: Davies, Melanie J.
Khunti, Kamlesh
First Published: Jul-2008
Publisher: Blackwell
Citation: Diabetes, Obesity and Metabolism, 2008, 10 (s2), pp. 42-49
Abstract: Type 2 diabetes mellitus (T2DM) and obesity commonly co-exist. Improved clinical management of T2DM and improved glycaemic control with traditional therapies including insulin usually results in some weight gain – a frequently perceived barrier to the introduction of insulin by both patient and healthcare professionals. Weight gain of 2.5 kg per 1% change in haemoglobin A1c (HbA1c) is common in many studies. Strategies to minimise weight gain, particularly in obese patients, are essential to help patients better manage their diabetes and improve quality of life. Insulin analogues, with lower risk of hypoglycaemia and better withinpatient variability compared with human insulin may help facilitate reaching treatment goals. Moreover, weight gain can be minimised by earlier insulinisation and the use of basal insulin, such as insulin glargine, instead of premixed insulin. Data specific to the obese patient with T2DM are presented; they are currently limited but do indicate that insulin glargine therapy is associated with improved glycaemic control as well as less weight gain than other insulins, including, premixed insulin and prandial insulin regimens. Retrospective subanalyses of earlier trials and on-going studies would shed further light on the impact of insulin therapy in obese people with T2DM, in addition to determination of optimal therapeutic strategies.
DOI Link: 10.1111/j.1463-1326.2008.00844.x
ISSN: 1462-8902
Type: Article
Rights: This is the author's final draft of the paper published as Diabetes, Obesity and Metabolism, 2008, 10 (s2), pp. 42-49. The definitive version is available at Doi: 10.1111/j.1463-1326.2008.00844.x
Appears in Collections:Published Articles, Dept. of Cardiovascular Sciences

Files in This Item:
File Description SizeFormat 
5. insulin glargine in obesity full manuscript v6 (for submission).pdf149.69 kBAdobe PDFView/Open

Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.